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Abstract
Limited information is available regarding the metabolic consequences of intestinal dysbio-
sis in dogs with acute onset of diarrhea. The aim of this study was to evaluate the fecal
microbiome, fecal concentrations of short-chain fatty acids (SCFAs), as well as serum and
urine metabolites in healthy dogs (n=13) and dogs with acute diarrhea (n=13). The fecal
microbiome, SCFAs, and serum/urine metabolite profiles were characterized by 454-pyro-
sequencing of the 16S rRNA genes, GC/MS, and untargeted and targeted metabolomics
approach using UPLC/MS and HPLC/MS, respectively. Significantly lower bacterial diversi-
ty was observed in dogs with acute diarrhea in regards to species richness, chao1, and
Shannon index (p=0.0218, 0.0176, and 0.0033; respectively). Dogs with acute diarrhea had
significantly different microbial communities compared to healthy dogs (unweighted Unifrac
distances, ANOSIM p=0.0040). While Bacteroidetes, Faecalibacterium, and an unclassified
genus within Ruminococcaceae were underrepresented, the genus Clostridium was over-
represented in dogs with acute diarrhea. Concentrations of fecal propionic acid were signifi-
cantly decreased in acute diarrhea (p=0.0033), and were correlated to a decrease in
Faecalibacterium (ρ=0.6725, p=0.0332). The predicted functional gene content of the
microbiome (PICRUSt) revealed overrepresentations of genes for transposase enzymes as
well as methyl accepting chemotaxis proteins in acute diarrhea. Serum concentrations of
kynurenic acid and urine concentrations of 2-methyl-1H-indole and 5-Methoxy-1H-indole-3-
carbaldehyde were significantly decreased in acute diarrhea (p=0.0048, 0.0185, and
0.0330, respectively). These results demonstrate that the fecal dysbiosis present in acute
diarrhea is associated with altered systemic metabolic states.
PLOS ONE | DOI:10.1371/journal.pone.0127259 May 22, 2015 1 / 24
OPEN ACCESS
Citation: Guard BC, Barr JW, Reddivari L,
Klemashevich C, Jayaraman A, Steiner JM, et al.
(2015) Characterization of Microbial Dysbiosis and
Metabolomic Changes in Dogs with Acute Diarrhea.
PLoS ONE 10(5): e0127259. doi:10.1371/journal.
pone.0127259
Academic Editor: Daniel Monleon, Instituto de
Investigación Sanitaria INCLIVA, SPAIN
Received: September 17, 2014
Accepted: April 14, 2015
Published: May 22, 2015
Copyright: © 2015 Guard et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: The sequences were
deposited in the Sequence Read Archive under the
following accession number: SRP040310.
Funding: "The author(s) received no specific funding
for this work."
Competing Interests: Co-author Jan Suchodolski is
a PLOS ONE Editorial Board member and this does
not alter our adherence to PLOS ONE Editorial
policies and criteria.
Introduction
Recent molecular studies have greatly increased our knowledge about the microbiota in the gas-
trointestinal tract (GIT) of dogs, mice, and humans [1–4]. The GIT microbiota plays an impor-
tant role in host health by stimulating the immune system, influencing gut structure, aiding in
the defense against pathogens, and providing nutritional benefits to the host (e.g., production of
SCFAs) [5–10]. Despite recent advances in characterizing microbial communities using sequenc-
ing technology, there remains a rudimentary understanding of the complex interactions that
occur between the host and intestinal microbes and their metabolic end-products. The analysis
of host and bacterial metabolites may give additional insights into the pathophysiology of gastro-
intestinal diseases, including acute diarrhea. Metabolomics is a relatively new field that aims to
characterize qualitatively and/or quantitatively the presence of small molecules in biological sam-
ples [11]. This approach may enhance our understanding of the host-microbe interactions, as
well as the metabolic pathways that are involved in health and disease. Initial metagenomic and
metabolomic studies performed in humans and animal models suggest that the metabolites de-
rived from diverse microbial communities may have a direct role in health and disease [12].
Therefore, more in-depth studies are needed to understand the relationships between the micro-
biome and the host [8]. Phylogenetic changes in intestinal microbiota have been previously de-
scribed in dogs with acute and chronic GI disease [13–15]. A previous study by our group has
compared the fecal microbiome between healthy dogs, dogs with IBD, and dogs with acute diar-
rhea, but reported only phylogenetic data based on 16S rRNA gene sequences and it is currently
unknown whether these microbiome changes are associated with metabolic changes in the host
[14]. Therefore, the aim of the present study was to evaluate a new cohort of dogs with acute diar-
rhea to confirm the previous findings, and also to elucidate whether microbiome changes based
on 16S rRNA genes are associated with metabolic and functional changes. We profiled the fecal
microbiome using 16S rRNA sequencing, measured and correlated fecal metabolic end products
(i.e., SCFAs) with bacterial groups, and inferred metagenomics using PICRUSt [16]. Further-
more, this study used Ultra Performance Liquid Chromatography-Mass Spectrometry
(UPLC-MS) in an untargeted metabolomics approach coupled with High Performance Liquid
Chromatography-Mass Spectrometry (HPLC-MS) in a targeted metabolomics approach to char-
acterize and confirmmetabolomic alterations in the serum and urine of dogs with acute diarrhea.
Materials and Methods
Animal enrollment and sample collection
Naturally passed feces, serum samples (collected by venipuncture), and urine samples (collect-
ed by cystocentesis) were obtained from healthy dogs as well as dogs with acute diarrhea (AD).
Dogs with AD were further classified as having non-hemorrhagic diarrhea (NHD) or hemor-
rhagic diarrhea (AHD) (Table 1). Feces were refrigerated immediately after collection, trans-
ferred within a few hours to a -80°C freezer, and stored frozen until processing for DNA
extraction. Serum and urine samples were aliquoted and stored frozen at -80°C until process-
ing. Owners provided written consent for their dogs to be used in this study. The collection of
feces, serum, and urine was approved by the Texas A&MUniversity Institutional Animal Care
and Use Committee (IACUC): Protocol Number; 2012–101. None of the healthy dogs or dogs
with acute diarrhea had been used in a previous study [14].
The control group consisted of 13 healthy pet dogs (Table 1, S1 Table). All dogs were pri-
vately owned, lived in various home environments, and were fed a variety of commercial diets.
None of the dogs had a history of gastrointestinal signs or administration of antibiotics for at
least a month prior to collection of fecal samples. All healthy dogs lived in Texas, USA.
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The diseased group consisted of 13 dogs in total with acute diarrhea (6 dogs with NHD and
7 dogs with AHD) that presented to the Veterinary Medical Teaching Hospital at Texas A&M
University with acute, non-hemorrhagic or hemorrhagic diarrhea (defined as duration of diar-
rhea<3 days) (Table 1, S1 Table). None of the dogs had a previous history of GI signs or had
received antibiotics within the previous three months. Diagnostic evaluation included a com-
plete blood count (CBC), serum chemistry profiles (SIRRUS Clinical Chemistry Analyzer),
serum concentrations of canine trypsin-like immunoreactivity (cTLI), serum concentrations of
canine pancreatic lipase immunocreactivity (cPLI), serum concentrations of cobalamin and fo-
late (Immulite 2000 Vitamin B12, Folic Acid, Siemens Medical Solutions Diagnostics), and
serum concentrations of C-reactive protein (CRP; Phase Range Canine C-reactive Protein
Assay, Tridelta Development Ltd), and urine analysis. None of the dogs with acute diarrhea
had been readmitted to the clinic at Texas A&M University after one month of initial presenta-
tion and for the purpose of this study their clinical signs were considered resolved.
DNA isolation
100 mg of feces were aliquoted into a sterile 1.7 ml tube (Microtube, Sarstedt AG & Co, Nüm-
brecht, Germany) containing 150 μl of 0.1 mm zirconia-silica beads and 100 μl of 0.5 mm zir-
conia-silica beads (BioSpec Products Inc., Barlesville, OK, USA). Samples were then
homogenized (FastPrep-24, MP Biomedicals, USA) for a duration of 1 minute at a speed of 4
m/s. DNA was then extracted with the ZR fecal DNAMini Prep kit following the manufactur-
er’s instructions (Zymo Research, Irvine CA, USA).
454-Pyrosequencing
Bacterial tag-encoded FLX-titanium amplicon pyrosequencing was performed targeting the
V4–V6 region of the 16S rRNA gene using forward and reverse primers: 530F (5’-
GTGCCAGCMGCNGCGG-3’) and 1100R (5’-GGGTTNCGNTCGTTG-3’), respectively [17].
Raw sequence data were screened, trimmed, de-noised, filtered, and depleted of chimeras using
the QIIME v1.7 open-source pipeline [18]. Operational taxonomic units (OTUs) were assigned
based on at least 97% sequence similarity using QIIME. The sequences were deposited in the
Sequence Read Archive under the following accession number: SRP040310.
Quantitative PCR (qPCR)
To evaluate specific bacterial groups of interest to intestinal health (i.e., Lactobacillus and Bifi-
dobacterium) and bacterial species with potential pathogenic roles (i.e., Escherichia coli, and
Clostridium perfringens) qPCR was used as described previously [19–21] and primers/probe
Table 1. Summary of basic characteristics and alpha diversity measures.
Healthy NHD AHD AD p-value
Age (years; median, range) 5.0, 1.0–12.0 1.0, 1.0–12.0 4.0, 1.0–10.0 3.0, 1.0–12.0 0.3988
Weight (kg; median, range) 20.4, 2.7–31.8 20.9, 7.3–31.6 16.9, 4.9–44.4 20.9, 4.9–44.4 0.7776
Sex (female/male) 8/5 4/1 2/4 6/5 0.9166
OTU97 (mean ± SD) 268.1
a ± 52.8 200.3 ± 48.5 204.6 ± 35.8 201.3b ± 56.7 0.0218
Shannon Index (mean ± SD) 4.8a ± 0.4 4.0b,c ± 0.2 3.9a,b,c ± 0.8 4.0c ± 0.6 0.0033
Chao1 (mean ± SD) 386.1a ± 80.6 291.2 ± 57.7 305.8 ± 109.7 303.6b ± 87.0 0.0176
NHD = acute non-hemorrhagic diarrhea; AHD = acute hemorrhagic diarrhea; AD = both groups combined (NHD and AHD).
Means not sharing a common superscript are significantly different (p<0.05 based on Dunn’s multiple comparisons test).
doi:10.1371/journal.pone.0127259.t001
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can be viewed in the S4 Table. Quantitative PCR reactions were performed using two reaction
chemistries. For a subset of assays SYBR-green based reaction mixtures were used, with a total
reaction volume of 10 μl. The final mix contained 5 μl SsoFast EvaGreen supermix (Bio-Rad
Laboratories, CA, USA), 0.4 μl each of a forward and reverse primer (final concentration: 400
nM), 2.6 μl of high quality PCR water, and 2 μl of normalized DNA (final concentration: 5 ng/
μl). Conditions for PCR were as follows: initial denaturation at 98°C for 2 min, then 40 cycles
with denaturation at 98°C for 3 sec and annealing (S4 Table) for 3 sec. Post-amplification, a
melt curve analysis was performed using these conditions: 95°C for 1 min, 55°C for 1 min, and
increasing incremental steps of 0.5°C for 80 cycles for 5 sec each. All samples were run in dupli-
cate fashion. TaqMan based reaction mixtures were used in a total reaction volume of 10 μl.
The final mix contained 5 μl TaqMan Fast Universal PCR master mix (Life Technologies, NY,
USA), 0.4 μl of a forward and reverse primer (final concentration: 400 nM), 2 μl of high quality
PCR water, and 2 μl of normalized DNA (final concentration: 5 ng/μl). Conditions for PCR
were as follows: initial denaturation at 95°C for 20 sec then 40 cycles with denaturation at 95°C
and annealing (S4 Table) for 3 sec. Post-amplification, a melt curve analysis was performed
using these conditions: 95°C for 1 min, 55°C for 1 min, and increasing incremental steps of
0.5°C for 80 cycles for 5 sec each. All samples were run in duplicate fashion.
Measurement of short-chain fatty acids
Analysis of short-chain fatty acids (SCFAs; i.e., acetate, propionate, and butyrate), and
branched chain fatty acids (BCFAs; i.e., isobutyrate, isovalerate, and valerate) in feces was per-
formed on a subgroup of dogs, as not all dogs had sufficient quantity of feces available. The
SCFA and BCFA were measured using a dilution gas chromatography-mass spectrometry
(GC-MS) assay as previously described [22] with some modifications. Briefly, the fecal samples
were weighed and diluted 1:5 in extraction solution (2N hydrochloric acid). After homogeniza-
tion using a multi-tube vortexer for 30 min at room temperature, fecal suspensions were centri-
fuged for 20 min at 2,100 x g and 4°C. Supernatants were then collected using serum filters
(Fisherbrand serum filter system, Fisher Scientific Inc, Pittsburgh, Pa). From each sample,
500 μl of supernatant were mixed with 10 μl of internal standard (200 mM heptadeuterated bu-
tyric acid) and extracted using a C18 solid phase extraction column (Sep-Pak C18 1 cc Vac
Cartridge, Waters Corporation, Milford, MA). Samples were derivatized using N-tert-butyldi-
methylsilyl-N-methyltrifluoroacetamide (MTBSTFA) at room temperature for 60 min. A gas
chromatographer (Agilent 6890N, Agilent Technologies Inc, Santa Clara, CA) coupled with a
mass spectrometer (Agilent 5975C, Agilent Technologies Inc, Santa Clara, CA) was used for
chromatographic separation and quantification of the derivatized samples. Separation was
achieved using a DB-1ms capillary column (30 m x 0.25 mm, 0.25 μm film thickness, Agilent
Technologies Inc, Santa Clara, CA). The GC temperature program was as follows: 40°C held
for 0.1 min, increased to 70°C by 5°C/min, 70°C held for 3.5 min, increased to 160°C by 20°C/
min, and finally increased to 280°C for 3 min by 35°C/min. The total run time was 20.53 min.
Solvent delay was 5 min. The mass spectrometer was operated in electron impact positive-ion
mode with selective ion monitoring at mass-to-charge ratios (M/Z) of 117 (acetate), 131 (pro-
pionate), 145 (butyrate and isobutyrate), 152 (deuterated butyrate; internal standard), and 159
(valerate and isovalerate). The estimate of the relative concentrations was based on the ratio of
the area under the curve of the internal standard for each fatty acid.
Measurement of dry weight
For determination of fecal dry weight, a 100 mg of feces from each sample was aliquoted into a
sterile 1.7 ml serum tube (Microtube, Sarstedt AG & Co, Nümbrecht, Germany). This aliquot
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was solely used in the determination of dry weight and thus was weighed and dried at 105°C in
an oven (Symphony Gravity Convection Oven, VWR) overnight. The percent of dry weight
was calculated and SCFA/BCFA concentrations were adjusted (measured in μmol/g of dry
feces for all SCFAs/BCFAs) to normalize by dry weight.
Untargeted metabolite detection in serum
Serum samples were thawed on ice and diluted 1:5 in cold methanol. The mixture was vor-
texed and incubated at -20°C for two hours to precipitate protein. The solution was centri-
fuged at 14,000 x g for 20 minutes at 4°C, and then the supernatant was collected and
transferred to a Waters 96 well autosampler plate. 1 μl injections were performed on a Waters
Acquity UPLC system. Separation was performed using a Waters Acquity UPLC C8 column
(1.8 μm, 1.0 x 100 mm), using a gradient from solvent A (95% water, 5% methanol, 0.1% for-
mic acid) to solvent B (95% methanol, 5% water, 0.1% formic acid). Injections were made in
100% A, which was held for 0.1 min, ramped to 40% B in 0.9 min, to 70% B over two min,
and to 100% B over 8 min. Mobile phase was held at 100% B for 6 min, returned to starting
conditions over 0.1 min, and allowed to re-equilibrate for 5.9 min. Flow rate was constant at
140 μl/min for the duration of the run. The column was held at 50°C and samples were held
at 10°C. Column Eluent was infused into a Waters Xevo G2 Q-TOF MS fitted with an electro-
spray source. Data was collected in positive ion mode, scanning from 50–1200 at a rate of 0.2
sec per scan. Collision energy was set to 6 Volts for MS mode, and ramped from 15 to 30 volts
for MSE mode. Calibration was performed prior to sample analysis via infusion of sodium
formate solution, with mass accuracy within 1 ppm. The capillary voltage was held at 2200
volts, the source temp at 150°C, and the desolvation temperature at 350°C at a nitrogen deso-
lvation gas flow rate of 800 L/hr.
Untargeted metabolite detection in urine
Analysis of metabolites was performed on a subgroup of dogs, as urine was unable to be collect-
ed from all dogs. Urine samples were diluted 1:2 in methanol, centrifuged, and transferred to a
Waters 96 well autosampler plate. The peak areas were first normalized based on total extracted
ion signal and then normalized based on urine creatinine concentrations measured by a SIR-
RUS Clinical Chemistry Analyzer. A volume of 5 μl was injected into a Waters Acquity UPLC
system. Separation was performed using a Waters Acquity UPLC T3 column (1.8 μm, 1.0 x 100
mm), using a gradient from solvent A (water, 0.1% formic acid) to solvent B (acetonitrile, 0.1%
formic acid). Injections were made in 100% A, which was held for 1 min, a 12 min linear gradi-
ent to 95% B was applied, and held at 95% B for 3 min, returned to starting conditions over
0.05 min, and allowed to re-equilibrate for 3.95 min. Flow rate was constant at 200 μl/min for
the duration of the run. The column was held at 50°C and the samples were held at 5°C. Col-
umn eluent was infused into a Waters Xevo G2 Q-TOF MS fitted with an electrospray source.
Data was collected in positive ion mode, scanning from 50–1200 at a rate of 0.2 sec per scan, al-
ternating between MS and MSE mode. Collision energy was set to 6 Volts for MS mode, and
ramped from 15 to 30 volts for MSE mode. Calibration was performed prior to sample analysis
via infusion of sodium formate solution, with mass accuracy within 1 ppm. The capillary volt-
age was held at 2200V, the source temp at 150°C, and the desolvation temperature at 350°C at
a nitrogen desolvation gas flow rate of 800 L/hr.
Targeted metabolite detection in serum and urine
Standards for Kynurenic Acid (IUPAC: 4-hydroxyquinooline-2-carboxyclic acid) and
2-methylindole were purchased from Sigma-Aldrich and were98% pure. The standard for
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5-Methoxy-1H-indole-3-carbaldehyde was purchased from Matrix Scientific and was98%
pure. The target compounds in samples were detected and quantified on a triple quadrupole
linear ion trap mass spectrometer (3200 QTRAP, AB SCIEX, Foster City, CA) coupled to a
binary pump HPLC (Prominence LC-20, Shimazu, Concord, Ontario, Canada). Peak identi-
fication and integration were performed using Analyst software (version 5, Agilent, Foster
City, CA). Samples were maintained at 4°C on an autosampler prior to injection. Chro-
matographic separation was achieved on a C-18 column (Synergi Fusion 4 μm 80 Å 150
mm × 2 mm, Phenomenex, Torrance, CA) using a solvent gradient method [23]. Solvent A
was formic acid solution in water (0.1%). Solvent B was acetonitrile with formic acid (0.1%).
Injection volume was 10 μL. For urine, concentrations of compound within each urine sam-
ple were normalized to urine creatinine concentration and expressed as ratios. Serum was
normalized by volume.
Statistical analysis
A subset of 6,900 sequences per sample was randomly selected to account for unequal sequenc-
ing depth across samples. Differences in microbial communities between healthy dogs, dogs
with NHD, and dogs with AHD were analyzed using the phylogeny-based unweighted UniFrac
distance metric, PCoA plots, and rarefaction curves generated by QIIME [18]. Rarefaction
curves and PCoA plots show alpha (i.e., Chao 1, Shannon Index, and Observed Species) and
beta (i.e., microbial community distance matrix) diversity, respectively. ANOSIM (Analysis of
Similarity) within the software package PRIMER 6 (PRIMER-E Ltd., Luton, UK) was used to
determine significant differences in microbial communities between healthy dogs and diseased
dogs. To visualize the relative abundance of bacterial families for individual fecal samples, heat
maps were generated in NCSS 2007 (NCSS, Kaysville, Utah).
All datasets were tested for normality using the Shapiro-Wilk test (JMP 10, SAS software
Inc.). Because most datasets did not meet the assumptions of normal distribution, compari-
sons between healthy and disease groups were determined using non-parametric Kruskal-
Wallis tests (healthy dogs vs. dogs with NHD vs. dogs with AHD) or a Mann-Whitney U test
(healthy dogs vs. dogs with acute diarrhea AD [dogs with NHD and dogs with AHD com-
bined]). Taxa that were present in at least 70% of dogs (either healthy or diseased) were in-
cluded in 454-pyrosequencing data analysis. The resulting p-values of the Kruskal-Wallis
tests or Mann-Whitney U test were adjusted for multiple comparisons using the Benjamini &
Hochberg’s False Discovery Rate (FDR), and an adjusted p<0.05 was considered statistically
significant [24]. A Dunn’s post-test was used to determine which disease types were signifi-
cantly different if applicable.
PICRUSt
The software PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unob-
served States) was used to make functional gene content predictions based on 16S rRNA gene
data present in the Greengenes database [25]. PICRUSt is freely available online in the Galaxy
workflow framework and can also be used through the QIIME open-source pipeline [26, 27].
LEfSe
Linear discriminant analysis effect size (LEfSe) was used to elucidate taxa and genes associated
with healthy or diseased states. For bacterial groups, the LDA score threshold was set to> 3.5;
for functional genes and their specific KEGG orthologs the LDA score threshold was set
to> 2.5. LEfSe is freely available online in the Galaxy workflow framework [26, 27].
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Short-chain fatty acids
Fecal SCFA concentrations were tested for normality and compared between each group using
a Mann-Whitney U test. SCFAs that were found to be significantly different between groups
were then correlated to differentially abundant bacterial groups (i.e., Spearman’s rank correla-
tion; JMP 10, SAS software Inc.).
Serum and urine untargeted metabolomics
Waters raw files were converted to netCDF format, and XCMS [28] peak detection, retention
time alignment, and feature grouping were performed on both the low and high collision ener-
gy channels (MS and MSe). The datasets were separated following alignment, normalized to
total extracted ion signal, averaged by injection replicate, and the idMS/MS workflow described
previously was applied to all significant features for generation of indiscriminant MS/MS
(idMS/MS) spectra for library searching and compound identification [29]. For identification
of spectra, recreated idMS/MS spectra were searched against the NIST ‘12 MS/MS database,
Metlin, and Massbank. idMS/MS spectra which matched database MS/MS spectra were as-
signed a level 2 identification confidence [30]. For urine, concentrations of compound within
each urine sample were normalized to urine creatinine concentration and expressed as ratios.
Serum was normalized by volume. After data pre-processing, principle component analysis
and univariate analysis was conducted using the web-based metabolomic data processing tool
MetaboAnalyst 2.0 [31, 32].
Results
Sequencing analysis
The analysis pipeline yielded 297,315 quality sequences for the 19 samples analyzed
(mean ± standard deviation [of all samples] = 9,013 ± 1,203). Fig 1 illustrates the rarefaction
curve for observed species (a count of all unique operational taxonomic units (OTUs)). All
alpha diversity measures are summarized in Table 1. Observed species were significantly de-
creased in dogs with acute diarrhea (p = 0.0218). The Shannon Index was significantly de-
creased in dogs with AD and NHD compared to healthy dogs (p = 0.0033 and p< 0.0500,
respectively). The Chao1 predictive diversity measure was also significantly decreased in dogs
with acute diarrhea (p = 0.0176).
Microbial communities
PCoA plots (Fig 2) based on unweighted Unifrac distances showed significant differences be-
tween healthy dogs and dogs with AD (ANOSIM; p = 0.0040). Furthermore dogs with NHD
and dogs with AHD differed significantly from healthy dogs (ANOSIM; p = 0.0020 for both).
There was no difference in microbial communities, however, between dogs with hemorrhagic
and non-hemorrhagic diarrhea. Based on LDA effect size (LEfSe), Clostridium spp. was signifi-
cantly associated with AD, while Prevotella spp., Blautia spp., Faecalibacterium spp., Eubacteri-
um spp., and unclassified genera within the following families: Ruminococcaceae,
Lachnospiraceae, Clostridia, Ruminococcaceae, and Coprobacillaceae were significantly associ-
ated with healthy dogs (Fig 3). A heatmap in Fig 4 was employed to illustrate these changes.
Table 2 and Fig 5A summarize differences in bacterial groups between disease groups. Se-
quences belonging to the phylum Bacteroidetes were significantly decreased in dogs with AD
compared to healthy dogs (p = 0.0280). Sequences belonging to the genus Faecalibacterium
and an unclassified genus within Ruminococcaceae were both significantly decreased in dogs
with AD compared to healthy dogs (p = 0.0319 and 0.0368, respectively). Sequences belonging
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to the genus Clostridium were significantly increased in dogs with AD compared to healthy
dogs (p = 0.0476). No differences were identified between dogs with hemorrhagic and non-
hemorrhagic acute diarrhea when evaluating bacterial groups.
Quantitative PCR
The abundance of Clostridium perfringens was significantly increased in dogs with AD (log
DNAmedian [range]: 7 [5.8–7.5]) compared to healthy dogs (log DNAmedian [range]: 4.6
[3–6.1]; p = 0.0088). Clostridium perfringens was also significantly increased in the subgroup
dogs with AHD (log DNAmedian [range]: 7.1 [6.9–7.4]) compared to healthy dogs
(p<0.0500). No significant difference in Bifidobacterium, Lactobacillus, or E. coli was identified
between dogs with acute diarrhea and healthy dogs (Fig 5B).
Functional genes
Univariate statistics revealed no significant differences in the percentage of KEGG orthologs
belonging to functional gene families at all levels (e.g., 1, 2, and 3) among all groups of dogs
after correcting for multiple comparisons (S2 Table). However, PICRUSt provided a snapshot
of the distribution of genes across functional categories. At level 1, approximately 50% of genes
belonged to metabolism, 19% belonged to genetic information processing, and 15% belonged
to environmental information processing. Next, functional gene categories were analyzed using
Fig 1. Rarefaction analysis of 16S rRNA gene sequences obtained from canine fecal samples. Lines represent the mean and error bars represent
standard deviations. The analysis was performed on a randomly selected subset of 6,900 sequences per sample. NHD = acute non-hemorrhagic diarrhea;
AHD = acute hemorrhagic diarrhea.
doi:10.1371/journal.pone.0127259.g001
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Fig 2. Principal Coordinate Analysis (PCoA) of unweighted UniFrac distances of 16S rRNA genes. Blue squares = healthy dogs, green circles = acute
non-hemorrhagic diarrhea (NHD), and red triangles = acute hemorrhagic diarrhea (AHD); ANOSIM for healthy dogs vs. dogs with AD (NHD and AHD
combined), p = 0.0040; and ANOSIM for NHD or AHD vs. healthy dogs, p = 0.0020 for both.
doi:10.1371/journal.pone.0127259.g002
Fig 3. Differentially abundant bacterial groups.Groups differentially abundant between healthy dogs and dogs with acute diarrhea. Red bars represent
bacterial groups associated with dogs with acute diarrhea, while green bars represent bacterial groups associated with healthy dogs.
doi:10.1371/journal.pone.0127259.g003
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LEfSe. The cladogram in Fig 6A shows functional genes associated with healthy dogs and dogs
with AD at all levels in the KEGG database hierarchy (LDA score threshold> 2.5). The follow-
ing pathways were associated with acute diarrhea: benzoate degradation within xenobiotics
biodegradation/metabolism, lipid metabolism, two component system within signal transduc-
tion, flagellar assembly/bacterial motility proteins/bacterial chemotaxis within cell motility,
and metabolism. The following pathways were associated with healthy dogs: methane metabo-
lism/oxidative phosphorylation within energy metabolism and chaperones/folding catalysts
within folding sorting/degradation.
In a separate analysis, KEEG orthologs (KOs) were analyzed by LEfSe without being catego-
rized by functional hierarchy (this strategy allows for more finite discovery of specific genes as-
sociated with healthy dogs or dogs with AD) (Table 3). KOs found to be associated with
healthy dogs were K07133, K07720, K02027, K02026, K0205, K10439, and K07718. These
genes are responsible for the multiple sugar transport system permease protein, multiple sugar
transport system substrate-binding protein, ribose transport system substrate-binding protein,
two-component system/sensor histidine kinase YesM, ATPase enzyme, and two-component
system/response regulator YesN, respectively. KOs found to be associated with dogs with acute
Fig 4. Heatmap illustrating the relative abundance of predominant bacterial genera in fecal samples. Healthy = healthy dogs; NHD = acute non-
hemorrhagic diarrhea; AHD = acute hemorrhagic diarrhea. “Unclass.” denotes an unclassified genus within the respective taxa.
doi:10.1371/journal.pone.0127259.g004
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Table 2. Percentages of the most abundant bacterial groups.
median(min-max) *in percent
Taxa Healthy Acute Diarrhea p-value
Phylum
Bacteroidetes 32.6(12.9–48.4) 15.3(0.0–27.9) 0.0280
Firmicutes 60.9(41.3–86.6) 72.2(32.7–99.9) 0.7213
Fusobacteria 4.5(0.1–12.7) 16.5(0.1–49.5) 0.0793
Proteobacteria 0.1(0.0–0.3) 0.1(0.0–1.2) 0.9596
unclass. bacteria 0.2(0.0–0.8) 0.3(0.0–0.4) 0.9008
Genus
Allobaculum 0.6(0.0–1.9) 0.1(0.0–5.7) 0.4284
Bacteroides 14.2(0.6–32.7) 12.5(0.0–18.9) 0.4530
Blautia 14.0(8.9–25.2) 3.6(0.2–19.8) 0.0977
Catenibacterium 0.3(0.0–13.2) 0.1(0.0–1.6) 0.2893
Clostridium 13.2(4.7–16.0) 31.2(0.3–53.8) 0.0476
Collinsella 0.3(0.1–1.7) 0.0(0.0–0.4) 0.1058
Dorea 1.5(0.3–12.6) 2.0(0.2–9.8) 0.8286
Enterococcus 0.0(0.0–0.2) 0.0(0.0–9.2) 0.8810
Escherichia 0.0(0.0–0.1) 0.0(0.0–0.5) 0.9574
Eubacterium 1.0(0.4–3.8) 0.1(0.0–1.0) 0.0504
Faecalibacterium 1.5(0.1–5.4) 0.1(0.0–1.1) 0.0319
Helicobacter 0.0(0.0–0.1) 0.0(0.0–0.1) 0.8866
J2-29 0.8(0.0–2.8) 3.5(0.0–8.2) 0.2570
Megamonas 1.9(0.1–20.5) 0.6(0.0–1.9) 0.4043
Peptococcus 0.2(0.0–1.3) 0.0(0.0–0.5) 0.3683
Phascolarctobacterium 0.0(0.0–1.3) 0.0(0.0–0.2) 0.1953
Prevotella 9.5(0.0–25.1) 0.0(0.0–1.7) 0.0896
[Prevotella] 2.5(0.0–11.6) 0.0(0.0–7.8) 0.2358
[Ruminococcus] 2.7(0.7–10.6) 2.8(0.1–15.6) 0.8770
Ruminococcus 0.1(0.0–0.2) 0.0(0.0–0.5) 0.7934
Slackia 0.0(0.0–0.1) 0.0(0.0–0.2) 0.7038
Streptococcus 0.3(0.0–1.3) 0.0(0.0–9.7) 0.3614
Turicibacter 0.0(0.0–2.2) 0.0(0.0–61.1) 0.2956
unclass. bacteria 0.2(0.0–0.8) 0.3(0.0–0.4) 0.9228
unclass. Bacteroidales 0.0(0.0–0.2) 0.0(0.0–0.1) 0.8348
unclass. Clostridia_1 0.4(0.1–0.9) 0.1(0.0–0.5) 0.1098
unclass. Clostridia_2 0.0(0.0–1.1) 0.0(0.0–0.7) 0.8142
unclass. Clostridiaceae 0.0(0.0–2.7) 0.0(0.0–1.8) 0.8022
unclass. Clostridiales 0.1(0.0–0.3) 0.2(0.0–0.3) 0.3854
unclass. Coprobacillaceae 0.7(0.0–2.6) 0.0(0.0–5.4) 0.1159
unclass. Firmicutes 0.2(0.0–0.4) 0.1(0.0–0.4) 0.5854
unclass. Fusobacteriaceae_1 0.0(0.0–0.3) 0.0(0.0–0.2) 0.9080
unclass. Fusobacteriaceae_2 3.2(0.1–11.8) 12.0(0.0–44.0) 0.2534
unclass. Lachnospiraceae_1 4.7(3.2–6.7) 1.6(0.2–3.6) 0.0840
unclass. Lachnospiraceae_2 0.4(0.0–0.6) 0.1(0.0–0.3) 0.0905
unclass. Lactobacillales 0.0(0.0–0.1) 0.0(0.0–0.1) 0.3629
unclass. Peptostreptococcaceae_1 0.0(0.0–0.0) 0.0(0.0–0.3) 0.7815
unclass. Peptostreptococcaceae_2 0.3(0.1–5.7) 0.1(0.0–4.5) 0.4253
unclass. Ruminococcaceae_1 0.1(0.0–0.3) 0.0(0.0–0.2) 0.0368
(Continued)
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diarrhea were K03406 and K07483. These genes are responsible for the methyl-accepting che-
motaxis protein and transposase enzyme, respectively. PICRUSt allows the user to determine
which taxa contribute to functional gene predictions (Fig 6B). To gain an overall understanding
of taxa contributing to identification of genes associated with acute diarrhea, only taxa contrib-
uting 500 or more gene counts were included in the bar charts. K03406 and K07483 were both
identified as genes that were significantly associated with acute diarrhea. The charts in Fig 6B
show that the family Clostridiaceae contributed mainly to genes coding for the methyl accept-
ing chemotaxis protein as well as the transposase enzyme (K03406 and K07483, respectively).
In addition, more gene counts appeared to be contributed by the family Clostridiaceae in dogs
with acute diarrhea compared to healthy dogs.
Short-chain fatty acids
Butyric acid, acetic acid, and propionic acid were each expressed as a percentage of the total
amount of fecal SCFA concentrations (Fig 7). The proportion of propionic acid was significantly
decreased in dogs with AD (median [range]:12% [0–25%]) compared to healthy dogs (median
[range]: 30% [20–44%]; p = 0.0033). In contrast, the proportion of butyric acid was significantly
increased in dogs with AD (median [range]: 12% [8–26%]) compared to healthy dogs (median
[range]: 6% [4–8%]; p = 0.0048). There were no significant differences in total fecal SCFA or
BCFA concentrations (μmol/g of dry feces) observed between groups of dogs (S3 Table).
Correlations between SCFA and bacterial groups
A positive correlation was observed between propionic acid and an unclassified genus within
Ruminococcaceae as well as Faecalibacterium (ρ = 0.8377 [p = 0.0042] and ρ = 0.6725
[p = 0.0332], respectively) (Fig 8). Butyric acid was found to have a negative correlation with
an unclassified genus within Ruminococcaceae (ρ = -0.8265 [p = 0.0027]. Furthermore, propi-
onic acid was negatively correlated with Lactobacillus (ρ = -0.8333 [p = 0.0424]).
Serum and urine metabolites
PCA plots showed no clustering in serum or urine metabolite profiles (Figs 9 and 10, respec-
tively) between healthy dogs and dogs with acute diarrhea. A total of 82 unique compounds
were identified in serum, while 362 unique compounds were identified in urine. Of these com-
pounds, none were significantly changed after adjusting for multiple comparisons in either of
the analyzed sample types. However, in serum, unadjusted p-values showed that the concentra-
tion of kynurenic acid in serum was significantly decreased in dogs with acute diarrhea com-
pared to healthy dogs (p = 0.0048). In addition to this comparison, the ratio between kynurenic
acid (K) and tryptophan (T) concentration in the serum of healthy dogs and dogs with acute
Table 2. (Continued)
median(min-max) *in percent
Taxa Healthy Acute Diarrhea p-value
unclass. Ruminococcaceae_2 0.0(0.0–0.2) 0.0(0.0–0.2) 0.1900
unclass. Streptococcaceae 1.8(0.0–10.8) 0.0(0.0–41.0) 0.3786
unclass. Veilonellaceae 0.1(0.0–1.1) 0.0(0.0–0.4) 0.4113
P-value adjusted based on the Benjamini and Hochberg False Discovery Rate.
The abbreviation "unclass." denotes an unclassified taxonomy within the respective taxonomic group.
doi:10.1371/journal.pone.0127259.t002
Microbial and Metabolomic Changes in Dogs with Acute Diarrhea
PLOS ONE | DOI:10.1371/journal.pone.0127259 May 22, 2015 12 / 24
Fig 5. Groups of interest based on A) Sequencing (% of sequences) and B) quantitative PCR results. The qPCR data was expressed as log amount
of DNA for each particular bacterial group per 10 ng of isolated total DNA. Acute Diarrhea = both groups combined (NHD and AHD). Bars represent the
median value for each group. P-values adjusted based on the Benjamini and Hochberg false discovery rate.
doi:10.1371/journal.pone.0127259.g005
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diarrhea was compared. The ratio of K/T was significantly decreased in dogs with acute diar-
rhea (p = 0.0036).
In urine, unadjusted p-values showed that the concentrations of 2-methyl-1H-indole and
5-Methoxy-1H-indole-3-carbaldehyde were significantly decreased in dogs with acute diarrhea
compared to healthy dogs (p = 0.0185 and 0.0330, respectively).
Fig 6. A) Differentially abundant gene families identified within healthy dogs and dogs with acute diarrhea. B) Taxa contributing to the MAC protein
gene and Tranposase enzyme gene (K03406 and K07483, respectively) (Table 3) in all dogs.H.__ = Healthy, A.__ = acute non-hemorrhagic diarrhea,
R.__ acute hemorrhagic diarrhea.
doi:10.1371/journal.pone.0127259.g006
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A targeted approach was used to confirm the identity and validity of compounds found to be
significantly altered from the untargeted metabolomics approach. The targeted approach for
serum kynurenic acid yielded a strong correlation to the untargeted approach (ρ = 0.7213 and
p = 0.0001) (S2 Fig). The targeted approach for urine 2-methyl-1H-indole and 5-Methoxy-1H-
indole-3-carbaldehyde yielded a moderate to strong significant correlation to the untargeted ap-
proach (ρ = 0.6569 and p = 0.0042, ρ = 0.8162 and p<0.0001; respectively) (S3 Fig)
Discussion
In this study we compared the fecal microbiome as well as serum and urine metabolomic pro-
files between healthy dogs and dogs with acute diarrhea. Our results revealed significant
changes in microbial communities in dogs with AD. Consistent with our previous findings in
dogs with acute diarrhea and similar to data observed in humans and mice, alpha diversity
measures were significantly decreased [14, 33, 34]. Principal coordinates analysis (PCoA) plots
revealed significant differences in microbiome composition between healthy dogs and dogs
with AD. We identified specific bacterial groups that were altered in disease. A significant in-
crease in Clostridium perfringens in dogs with AD was observed as reported previously [5, 14].
In contrast, bacterial groups decreased in AD were Bacteroidetes, Faecalibacterium, and an un-
classified genus within Ruminococcaceae. Some of these bacterial groups are believed to be im-
portant producers of various metabolites including SCFAs [35], and consequently, we observed
significant differences in SCFAs patterns between healthy and diseased dogs, with propionic
Table 3. KEGG orthologs and functions that are highly abundant.
Group KEGG ortholog LDA score Function
Healthy K02025 2.9 multiple sugar transport system permease protein
Healthy K02026 2.8 multiple sugar transport system permease protein
Healthy K02027 2.8 multiple sugar transport system substrate-binding protein
Healthy K10439 2.7 ribose transport system substrate-binding protein
Healthy K07718 2.6 two-component system, sensor histidine kinase YesM
Healthy K07133 2.6 ATPase
Healthy K07720 2.5 two-component system, response regulator YesN
Acute Diarrhea K03406 2.7 methyl-accepting chemotaxis protein
Acute Diarrhea K07483 2.6 transposase
Performed by LEfSe using LDA score cutoff > 2.5.
doi:10.1371/journal.pone.0127259.t003
Fig 7. Proportion of total fecal SCFA concentrations. Circles = healthy dogs; Squares = acute diarrhea both groups combined (NHD and AHD). Bars
represent the median value for each group. P-values adjusted based on the Benjamini and Hochberg false discovery rate.
doi:10.1371/journal.pone.0127259.g007
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Fig 8. Correlations between SCFAs and bacterial groups. A) Correlations between butyric acid and select
bacterial groups. B) Correlations between propionic acid and select bacterial groups.
doi:10.1371/journal.pone.0127259.g008
Microbial and Metabolomic Changes in Dogs with Acute Diarrhea
PLOS ONE | DOI:10.1371/journal.pone.0127259 May 22, 2015 16 / 24
acid being significantly decreased in dogs with AD. However, unexpectedly butyric acid was
significantly increased in dogs with AD. Studies in humans have demonstrated the importance
of SCFAs such as butyrate and propionate. For example, propionic acid has recently garnered
attention for its protective effects against carcinogenesis and colorectal cancer in humans [36].
Butyrate protects against colitis by inducing apoptosis in cells with DNA damage, and also in-
creases the expression of tight junction proteins thereby reinforcing colonic defense barriers
[37–39]. Based on a decrease in Faecalibacterium, which has been identified as a butyrate pro-
ducing bacteria in humans [40, 41], a decrease in fecal butyrate concentrations was expected in
this study. This, however, was not observed. It is possible that dogs with acute diarrhea experi-
enced decreased utilization of butyric acid by the colonic epithelium and consequently butyric
acid was excreted and found in higher concentrations in the feces. Faecalibacterium and an un-
classified genus within Ruminococcaceae shared a positive correlation with propionic acid. Al-
terations in fecal propionic acid could possibly be due to decreased production and/or
increased absorption into the gut epithelium during stages of acute diarrhea. Therefore, it
Fig 9. Analysis of serummetabolites. A) Principle component analysis plot where red dots represent dogs with acute diarrhea while green dots represent
healthy dogs. Ellipses show the 95% confidence distribution for each group. B) Relative concentration of kynurenic acid, tryptophan, and their ratio to one
another in serum (p = 0.0048, 0.8282, and 0.0036; respectively).
doi:10.1371/journal.pone.0127259.g009
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appears that the dysbiosis in AD had direct impact on concentration of SCFA and this warrants
further research into potential therapeutic applications. Despite these findings, it is important
to note that measuring fecal SCFAs may not directly represent colonic conditions and further
studies are needed to investigate SCFA concentrations in vivo.
PICRUSt was used to infer putative metagenomes from16S rRNA gene profiles [16]. In gen-
eral, there was a homogenous distribution of genes across broad functional categories, which
has been previously noted in literature [42]. For instance, the abundance of genes belonging to
metabolism (50%), Genetic Information Processing (20%), Environmental Information Pro-
cessing (15%), and Cellular Processes (1–2%) were similar across healthy and diseased dogs.
This similarity between both groups could be due to convergence in gene content among bacte-
ria that inhabit the GIT. LEfSe was used to identify differentially abundant functional genes
(i.e., KEGG orthologs) that had not yet been grouped into families and some notable differ-
ences were identified. The methyl-accepting chemotaxis (MAC) protein gene (K03406) was
significantly increased in AD. The MAC protein is an integral component of ribose and galac-
tose chemoreceptors in Escherichia coli and has been suggested to play a role in the pathogene-
sis of E. coli [43]. It may be hypothesized that an increase in the number of genes encoding the
MAC protein may contribute to the survival of pathogenic microorganisms that ultimately
cause acute diarrhea [44, 45]. A gene encoding transposases (K07483) was also found to be sig-
nificantly more abundant in AD. Transposases can induce various types of genome rearrange-
ments and are a major cause of mutations [46]. In part, they can be detrimental by inactivating
housekeeping genes or impairing the chromosomes integrity [47]. Adversely, transposases are
essential to horizontal gene transfer (HGT), which in turn is largely responsible for the
Fig 10. Analysis of urine metabolites. A) Principle component analysis plot where red dots represent dogs with acute diarrhea while green dots represent
healthy dogs. Ellipses show the 95% confidence distribution for each group. B) Relative concentration of 2-methylindole and 5-methoxy-1H-indole-
3-carbaldehyde in serum (p = 0.0185 and 0.0330, respectively).
doi:10.1371/journal.pone.0127259.g010
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diversity, strong selection, and co-evolution of microbiota in humans [48]. Transposases were
recently identified as enzymes largely effected by HGT in a large-scale comparative metage-
nomic analysis of human fecal samples. Evaluating transposase and HGT activity may help de-
termine functional factors that that contribute to GI disease. Alterations in functional genes
greatly increase our understanding of the disease processes during acute diarrhea. However,
given the limitations of PICRUSt as solely a predictor of metagenomic function, a true metage-
nomics approach is warranted and may yield more in-depth resolution.
Serum and urine metabolites were evaluated using an untargeted metabolomics approach.
While we observed major changes in microbial communities, only a few serum or urine metab-
olites were significantly altered before adjusting for multiple comparisons. However, after ad-
justment this significance was lost. A possibility is that acute onset of diarrhea leads to only
minor systemic changes detectable in serum or urine due to the short time of disease. This may
be in contrast to chronic GI inflammation, where alterations of serum metabolites associated
with oxidative stress have been observed in dogs with IBD [20]. Another explanation is possibly
due to a limited sample size in conjunction with a large set of comparisons which were used for
statistical adjustment for multiple comparisons. This adjustment is inherently conservative
given the breadth of metabolites discovered by an untargeted metabolomics approach. There-
fore, targeted assays with standards were developed to validate the serum and urine metabolites
that were significantly altered based on unadjusted p-values. The results of the targeted assays
correlated significantly with the untargeted metabolomics data verifying the results.
Although it has long been recognized that the enteric community of bacteria broadly im-
pacts host health, the biochemical products they produce are only recently becoming better un-
derstood. In this study, derivatives and metabolic end products of tryptophan (i.e.,
2-methylindole, 5-methoxy-1H-indole-3-carbaldehyde) were significantly decreased in the
urine of dogs with acute diarrhea. These alterations may reflect a difference in uptake or utiliza-
tion. While the relationship between indole and indole-like compounds is unclear in the con-
text of dogs with acute diarrhea, it is interesting to note that indole has been shown to increase
expression of genes involved in strengthening of the mucosal barrier and mucin production
[49]. Also, the same study showed that indole decreased TNF-αmediated activation of NF-κB,
as well as increased expression of the anti-inflammatory cytokine IL-10 [49]. Kynurenic acid, a
catabolic derivative of tryptophan, was significantly decreased in the serum of dogs with AD
[49]. The importance of kynurenic acid in GI disease is not yet fully understood but warrants
further attention. The intestinal mucosa can monitor microbial ligands via pattern recognition
receptors and microbial metabolites via G-protein coupled receptors (GPRs), and GPR35 is
thought to be activated by kynurenic acid [50–52]. Recently, a study reported decreased muco-
sal but increased systemic levels of kynurenic acid in patients with irritable bowel syndrome
(IBS) [53]. Indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3,-dioxygenase (TDO) are
two enzymes implicated in catabolism of tryptophan and production of kynurenine. These en-
zymes play a central role in the physiological regulation of tryptophan alterations in the
human body and catalyze the first and rate limiting step of tryptophan degradation along the
kynurenine pathway [54]. Studies in humans with other forms of GI disease such as Crohn’s
disease (CD) have suggested that aberrant handling of luminal bacteria by the innate immune
system results in an activated inflammatory cascade and secretion of cytokines (i.e., TNF-α
and IFN-γ) [55, 56]. These cytokines are thought to be responsible for triggering enzymatic ac-
tivation of IDO and subsequent catabolism of tryptophan to form kynurenine. It may be hy-
pothesized that the enzymatic activation of IDO could negatively impact the immune system;
however this conjecture warrants further research.
The kynurenine/tryptophan ratio is used as a surrogate marker for IDO1 (i.e., the gene re-
sponsible for IDO) activity in patients with CD [57]. In a well-characterized cohort of CD
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patients and controls, one study found that serum tryptophan was decreased while the kynure-
nine/tryptophan ratio was increased in active CD [58]. While kynurenine was not measured in
this study, the ratio of serum kynurenic acid to tryptophan was investigated and found to be
significantly decreased in dogs with acute diarrhea. It’s not surprising that these results do not
align as the kynurenine/tryptophan ratio is often used to measure up- or down-regulation of
the kynurenine pathway and unfortunately in this case we were unable to readily measure
kynurenine, only one of its derivatives. It may be useful to target and monitor changes in
kynurenine and tryptophan in a longitudinal study which may provide a clearer picture of the
role these metabolites play in disease processes.
This study had limitations. Only a small number of animals were enrolled in the disease and
healthy group. In this respect, we acknowledge that results should be viewed as descriptive and
are useful in justifying larger scale studies to further confirm our findings. Evaluating pet dogs liv-
ing in various home environments is inherently difficult due to differences in size, weight, obesity
status and sex (intact vs. not-intact). In this study, the potential influence of gender on microbial
communities (S1 Fig) was investigated using the unweighted Unifrac distance matrix on all dogs
and there were no significant differences between males or females (ANOSIM: p = 0.6400) re-
gardless of sexual status (ANOSIM: p = 0.7900). Studies in humans and mice have indicated that
obesity plays a role in microbiome composition [59, 60]. The current data in dogs regarding the
intestinal microbiome in dogs is conflicting, and a previous study has not shownmajor differ-
ences between lean and obese pet dogs [61]. The body condition score (BCS, on a scale of 1–9
with 4–5 being ideal) used to differentiate between lean and obese dogs (S1 Table) was fairly het-
erogeneous amongst all dogs and clustering analysis of unweighted Unifrac distances revealed no
significant clustering by BCS. Additionally, in some instances, only a limited amount of sample
was available; therefore some samples could not be included for all analyses. Therefore, it is possi-
ble that some alterations may have been overlooked. All dogs were housed in different home en-
vironments before presentation, which may have a minor effect on GI microbiota. Diet has also
been shown to alter the intestinal microbiota [62]. However, in this study, dogs in both groups
were on a maintenance diet, so this fact likely had a minimal effect on microbial groups.
Conclusions
Results of this study revealed a bacterial dysbiosis in fecal samples of dogs with acute diarrhea.
Microbial diversity was significantly decreased and microbial communities differed significant-
ly in dogs with AD. Predicted gene families were conserved across both groups of dogs. Fur-
thermore, propionic acid was significantly correlated with a loss in SCFA producing bacteria
(i.e., Faecalibacterium). The fecal dysbiosis was associated with significant changes in profiles
of fecal SCFA and serum and urine metabolites. This suggests that acute episodes of diarrhea,
even when uncomplicated, have an impact on the overall metabolic profile of the host.
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